Stay updated on Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin
Sign up to get notified when there's something new on the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page.

Latest updates to the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page
- Check7 days agoChange DetectedThe page displays a new revision tag 'Revision: v3.5.5' replacing the previous revision label, indicating a small update to the page template.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication list updated with a new Lancet Neurology article on cognitive impairment in type 2 diabetes and a revision to v3.5.4, while the prior Lancet Neurology entry with an Erratum was removed and its revision updated to v3.5.3.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedA site revision tag was updated from v3.5.2 to v3.5.3 on the page, indicating a recent site maintenance update. This change does not affect the study content, outcomes, or how users interact with the study record.SummaryDifference0.0%

- Check50 days agoChange DetectedUpdated the Puerto Rico site listing to use “Manati” instead of “Manatí,” and added a new publication citation in the publications section.SummaryDifference0.0%

- Check57 days agoChange DetectedA publication citation was added and then removed, leaving the Publications list unchanged.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded a Lancet Diabetes Endocrinology publication on erectile function in men with type 2 diabetes treated with dulaglutide to the Publications section. Removed the associated Erratum entry and updated the revision metadata to v3.5.0, removing the previous v3.4.3 record.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Diabetes & Cardiovascular Events Weekly Incretin page.